BFRI
Biofrontera
$1.05
−$0.04 (−3.67%)Jul 27, 2026
Key metrics
The numbers that frame BFRI today
- Market cap
- $13.44M
- P/E (TTM)
- -1.2
- EV / FCF
- -1.6
- Gross margin
- 77.3%
- EV / Sales
- 0.3
- ROIC
- -113%
- Div yield
- 0%
- Debt / equity
- 1.3
- 52wk Low
- $0.56
- 52wk High
- $1.21
Growth
Revenue and earnings trend for BFRI
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about BFRI
Is Biofrontera a good buy?
No. Biofrontera has poor quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Biofrontera is selling at a very high price.
What is the market capitalization of BFRI?
Biofrontera's market capitalization is $13.44M.
What is the P/E ratio for BFRI stock?
Biofrontera's current P/E ratio is -1.2.
What is the 52-week high for BFRI stock?
The 52-week high for Biofrontera is $1.21. The current close of $1.05 is 12.9% below that high.
What is the 52-week low for BFRI stock?
The 52-week low for Biofrontera is $0.56. The current close of $1.05 is 89.2% above that low.
Does BFRI stock pay dividends?
Biofrontera does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for BFRI?
Biofrontera's Debt / Equity ratio is 1.27.